Founded in 2019 with scientists Hong Bo, Bai Lu and Hongjiang Zhang, Gnosis Neurodynamics brings together neuroscience, engineering and clinical applications. With roots in Tsinghua University’s neural engineering research, we focus on BCI data and foundation models. Our three business areas span intelligent clinical platforms, precision neurotechnology, and individual digital brains for CNS drug research. Beijing focuses on models, Xiong’an on innovation, and Shanghai on application.
Three Areas of Focus
Connecting neuroscience with clinical care, precision interventions and drug research.
Clinical BCI & Intelligent Care
Connecting EEG acquisition, intelligent analysis, multimodal data and remote collaboration. We support everyday hospital workflows and the development of BCI wards and regional brain data centers.
Precision Neurotechnology
Combining EEG, SEEG and imaging to understand individual brain networks. Fusion visualization and neurodynamic models support research and applications in neurosurgery, rehabilitation and neuromodulation.
Digital Brains & CNS Research
Working with hospitals, researchers and pharmaceutical partners to explore digital biomarkers, patient stratification and longitudinal brain function, using individual digital brains in CNS research.
NeuroFusion
A next-generation BCI platform
Connect multimodal brain data, individual digital brains and AI workflows in a shared space-and-time framework.
NeuroFusion brings data quality, analysis, research collaboration and model applications together.
Play the ten-second interface demonstration.
Company News
BPD 2026 · Shanghai
On August 6–7, 2026, Gnosis Neurodynamics joined the 9th Biopharmaceutical Bioprocessing Development Summit. Dr. Yuxiang Yan shared research on digital human brain modeling for CNS drug development. The team explores EEG biomarkers, patient stratification and virtual interventions, connecting neuroscience and data technology with clinical and industry research.
